Liver and Biliary Pathology — MCQs

Liver and Biliary Pathology Indian Medical PG Practice Questions and MCQs

Question 331: Which of the following is NOT true about Fibrolamellar carcinoma of the liver?

A. It has an increased incidence in females compared to males.
B. It generally has a good prognosis.
C. It is not associated with liver cirrhosis.
D. Serum AFP levels are usually >1000 ng/mL. (Correct Answer)

Explanation: Fibrolamellar Carcinoma (FLC) is a distinct variant of Hepatocellular Carcinoma (HCC) that differs significantly from conventional HCC in its clinical presentation and laboratory findings. **Why Option D is the correct answer:** In conventional HCC, serum Alpha-Fetoprotein (AFP) is often significantly elevated [1]. However, in **Fibrolamellar Carcinoma, serum AFP levels are typically normal** or only minimally elevated. This is a high-yield diagnostic differentiator. Instead, these patients may show elevated serum neurotensin or vitamin B12-binding capacity. **Analysis of other options:** * **Option A:** Unlike conventional HCC, which has a strong male predominance [2], FLC has an **equal sex distribution** or a slight female predominance. * **Option B:** FLC generally carries a **better prognosis** than conventional HCC. This is partly because it occurs in younger patients without underlying liver disease, making them better candidates for surgical resection [1]. * **Option C:** FLC characteristically arises in **non-cirrhotic livers**. There is no association with Hepatitis B, Hepatitis C, or alcohol-induced liver damage [2]. **NEET-PG High-Yield Pearls:** * **Age Group:** Typically affects young adults (20–40 years). * **Gross Morphology:** Presents as a single, large, hard "scirrhous" tumor with a characteristic **central stellate scar** (resembling Focal Nodular Hyperplasia). * **Microscopy:** Large, polygonal cells with abundant eosinophilic cytoplasm (due to numerous mitochondria) separated by **parallel lamellae of collagen bundles**. * **Genetic Marker:** A characteristic **DNAJB1-PRKACA** gene fusion is found in nearly all cases. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 399-400. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 876-877.

Question 332: Which of the following statements are true about alpha-1-antitrypsin deficiency?

A. Autosomal dominant disease, Emphysema, Fibrosis of portal tract
B. Autosomal dominant disease, Fibrosis of portal tract, Diastase resistant positive hepatocytes
C. Emphysema, Fibrosis of portal tract, Diastase resistant positive hepatocytes (Correct Answer)
D. Emphysema, Diastase resistant positive hepatocytes

Explanation: **Explanation:** Alpha-1-antitrypsin (AAT) deficiency is a genetic disorder characterized by the misfolding of the AAT protein, primarily due to the **PiZ mutation** [1]. This leads to two distinct pathological processes: 1. **Liver Pathology:** The misfolded protein cannot be secreted and accumulates within the endoplasmic reticulum of hepatocytes [1]. These accumulations appear as **PAS-positive, diastase-resistant eosinophilic globules**. Chronic accumulation leads to hepatocyte injury, inflammation, and eventually **fibrosis of the portal tract** and cirrhosis [1]. 2. **Lung Pathology:** Since AAT (a protease inhibitor) fails to reach the lungs, there is unchecked activity of neutrophil elastase [1, 2]. This destroys the alveolar walls, resulting in **panacinar emphysema** [2, 3]. **Analysis of Options:** * **Option C (Correct):** Accurately identifies the triad of lung involvement (emphysema), liver structural damage (portal fibrosis), and the classic histological hallmark (diastase-resistant globules). * **Options A & B (Incorrect):** These state the disease is autosomal dominant. AAT deficiency follows an **autosomal codominant** inheritance pattern [1]. * **Option D (Incorrect):** While the facts listed are true, it is less comprehensive than Option C, which includes the critical finding of portal fibrosis. **High-Yield NEET-PG Pearls:** * **Genetics:** Located on Chromosome 14 (SERPINA1 gene). PiMM is normal; **PiZZ** is the most severe phenotype [1, 2]. * **Histology:** PAS stain highlights the globules; diastase digestion is used to differentiate them from glycogen (glycogen washes away with diastase, AAT globules do not) [1]. * **Clinical:** It is the most common genetic cause of liver disease in children. In adults, suspect AAT deficiency in a non-smoker presenting with lower-lobe emphysema [2]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 856-858. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, pp. 683-684. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, pp. 684-685.

Question 333: In chronic inflammation confined to portal tract with intact limiting membrane and normal lobular parenchyma, what is the histopathological diagnosis?

A. Active hepatitis
B. Chronic active hepatitis
C. Chronic persistent hepatitis (Correct Answer)
D. Alcoholic hepatitis

Explanation: ### Explanation The question describes the classic histological presentation of **Chronic Persistent Hepatitis (CPH)**. #### 1. Why the Correct Answer is Right Historically, chronic hepatitis was classified based on morphological patterns of inflammation and necrosis. In **Chronic Persistent Hepatitis**, the inflammatory infiltrate (primarily lymphocytes) is strictly **confined to the portal tracts** [1]. The hallmark of this condition is an **intact limiting plate** (the layer of hepatocytes bordering the portal tract). Because there is no "spillover" of inflammation into the lobule, the lobular architecture remains preserved, and there is no significant piecemeal necrosis [1]. #### 2. Why Other Options are Wrong * **Chronic Active Hepatitis (CAH):** Unlike CPH, CAH is characterized by **interface hepatitis** (piecemeal necrosis), where the inflammation breaches the limiting plate and destroys adjacent hepatocytes [1]. It often leads to bridging necrosis and eventually cirrhosis. * **Active Hepatitis:** This is a general term usually referring to ongoing necro-inflammatory activity (acute or chronic) but lacks the specific morphological confinement to the portal tract described in the stem. * **Alcoholic Hepatitis:** This presents with a distinct triad: **Mallory-Denk bodies**, hepatocyte swelling (ballooning degeneration), and **neutrophilic infiltration**, typically in a centrilobular (Zone 3) distribution, rather than isolated portal inflammation. #### 3. NEET-PG Clinical Pearls * **Interface Hepatitis (Piecemeal Necrosis):** The defining feature that separates "Active" from "Persistent" chronic hepatitis [1]. * **Ground Glass Hepatocytes:** Associated with Chronic Hepatitis B (HBsAg accumulation in the ER) [1]. * **Current Classification:** Modern pathology has moved away from the CPH/CAH nomenclature toward a **Grading (activity)** and **Staging (fibrosis)** system (e.g., METAVIR or Batts-Ludwig scores) [1]. * **Limiting Plate:** Its integrity is the key diagnostic differentiator in this question. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 843-845.

Question 334: In post-hepatic jaundice, the concentration of conjugated bilirubin in the blood is higher than that of unconjugated bilirubin because:

A. There is an increased rate of destruction of red blood cells.
B. The unconjugated bilirubin is trapped by the bile stone produced in the bile duct.
C. The conjugation process of bilirubin in the liver remains operative without any interference. (Correct Answer)
D. The UDP-glucuronosyltransferase activity is increased manifold in obstructive jaundice.

Explanation: **Explanation:** **1. Why Option C is Correct:** Post-hepatic (obstructive) jaundice occurs due to an obstruction in the biliary tree (e.g., gallstones or tumors) after the liver has already processed the bilirubin [1]. In this condition, the liver's functional capacity to uptake and conjugate bilirubin remains intact. The hepatocytes continue to convert water-insoluble unconjugated bilirubin (UCB) into water-soluble **conjugated bilirubin (CB)** using the enzyme UDP-glucuronosyltransferase [4]. However, because the exit route (bile duct) is blocked, the conjugated bilirubin "backs up" and leaks from the hepatocytes or bile canaliculi into the systemic circulation [2]. Thus, the blood shows a predominance of conjugated bilirubin. **2. Why Other Options are Incorrect:** * **Option A:** Increased destruction of RBCs (hemolysis) leads to **Pre-hepatic jaundice**, characterized by an elevation of *unconjugated* bilirubin, as the liver is overwhelmed by the high heme load [1]. * **Option B:** Bilirubin is not "trapped" by stones; rather, the physical obstruction prevents the flow of bile into the intestine, causing a pressure-induced regurgitation of conjugated bilirubin into the blood [2]. * **Option D:** While UDP-glucuronosyltransferase is the conjugating enzyme, its activity is not "increased manifold" as a compensatory mechanism in obstruction; it simply continues to function at its normal physiological rate [4]. **3. High-Yield Clinical Pearls for NEET-PG:** * **Van den Bergh Reaction:** Post-hepatic jaundice gives a **Direct Positive** reaction (measures conjugated bilirubin). * **Urine/Stool Findings:** In obstructive jaundice, urine is dark (due to conjugated bilirubinuria), but **urobilinogen is absent** [3]. Stools are often **clay-colored** (acholic) due to the lack of stercobilin [3]. * **Marker Enzymes:** Obstructive jaundice is characterized by a disproportionate rise in **Alkaline Phosphatase (ALP)** and **GGT** compared to ALT/AST. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 384-385. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 385-386. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 380-381. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 858-860.

Question 335: In chronic viral hepatitis, what does grading refer to?

A. Hepatitis A virus infection is a common cause in children.
B. Morphological classification into Chronic Active Hepatitis and Chronic Persistent Hepatitis is important.
C. Fatty change is pathognomic of Hepatitis C virus infection.
D. Grading refers to the extent of necrosis and inflammation. (Correct Answer)

Explanation: In chronic viral hepatitis, the assessment of a liver biopsy is standardized using two distinct parameters: **Grading** and **Staging** [1]. ### Why the Correct Answer is Right **Grading** refers to the **intensity of necro-inflammatory activity**. It is a measure of the severity of the ongoing disease process [1]. Pathologists evaluate features such as interface hepatitis (piecemeal necrosis), confluent necrosis, lobular inflammation, and portal inflammation. Common scoring systems used include the **Metavir score** and the **Ishak (Modified Knodell) score**. ### Why the Other Options are Wrong * **Option A:** Hepatitis A virus (HAV) and Hepatitis E virus (HEV) cause **acute** hepatitis and do not progress to chronic hepatitis [2]. Chronic hepatitis is primarily caused by HBV, HCV, and HDV. * **Option B:** The older classification into "Chronic Active" and "Chronic Persistent" hepatitis is **obsolete**. Modern pathology focuses on specific etiology, grade of activity, and stage of fibrosis. * **Option C:** While **macrovesicular steatosis** (fatty change) is a characteristic feature of Hepatitis C (especially Genotype 3), it is **not pathognomonic** [1]. Pathognomonic features are those that allow for a definitive diagnosis alone; fatty change can also be seen in NAFLD or alcoholic liver disease. ### NEET-PG High-Yield Pearls * **Grading:** Necrosis + Inflammation (Active process) [1]. * **Staging:** Extent of **Fibrosis** and progression to Cirrhosis (Structural damage) [1]. * **Ground-glass hepatocytes:** Characteristic of Chronic Hepatitis B (due to HBsAg accumulation in the ER) [1]. * **Lymphoid aggregates** in portal tracts and **bile duct damage**: Highly suggestive of Chronic Hepatitis C [2]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 843-844. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 844-845.

Question 336: Von-Meyenburg's complexes are typically found in which organ?

A. Brain
B. Liver (Correct Answer)
C. Kidney
D. Spleen

Explanation: **Explanation:** **Von-Meyenburg Complexes (VMCs)**, also known as **biliary hamartomas**, are small, benign malformations of the intrahepatic bile ducts [1]. They occur due to the failure of the embryonic ductal plate to remodel during development [1]. 1. **Why Liver is Correct:** VMCs are specifically located in the **liver**. Histologically, they consist of clusters of dilated, irregular, or angulated bile ducts embedded in a dense fibrocollous stroma [1]. These ducts are lined by a single layer of cuboidal biliary epithelium and often contain "bile plugs" or proteinaceous material. While usually asymptomatic and discovered incidentally, they are important because they can mimic metastatic disease on imaging (appearing as multiple small, subcapsular hypoechoic nodules). 2. **Why Other Options are Incorrect:** * **Brain:** Common congenital lesions include hamartomas (e.g., in Tuberous Sclerosis), but VMCs are not found here. * **Kidney:** While VMCs are associated with **Autosomal Dominant Polycystic Kidney Disease (ADPKD)** and Polycystic Liver Disease [1], the complexes themselves are hepatic lesions, not renal. * **Spleen:** Splenic hamartomas exist (splenomas), but they are composed of red pulp elements, not biliary structures. **High-Yield Clinical Pearls for NEET-PG:** * **Association:** VMCs are part of the spectrum of **Fibropolycystic Liver Diseases**, which includes Caroli disease and Congenital Hepatic Fibrosis [1]. * **Imaging:** On MRI, they appear as "starry sky" patterns (multiple small hyperintense lesions on T2-weighted images). * **Malignant Potential:** Though benign, they are rarely considered precursors to **cholangiocarcinoma**. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 881-882, 868.

Question 337: A patient presents with arthritis, hyperpigmentation of skin, and hypogonadism. What is the likely diagnosis?

A. Hemochromatosis (Correct Answer)
B. Ectopic ACTH secreting tumor of the lung
C. Wilson's disease
D. Rheumatoid arthritis

Explanation: ### Explanation **Correct Option: A. Hemochromatosis** Hemochromatosis is a disorder of iron overload where excessive iron is deposited in various organs, leading to a classic clinical triad known as **"Bronze Diabetes."** The presentation in the question highlights the multi-system involvement: * **Skin:** Iron deposition and increased melanin production lead to **hyperpigmentation** (bronzing). * **Joints:** Deposition of calcium pyrophosphate (pseudogout) and iron in the joints causes **arthritis**, typically involving the 2nd and 3rd metacarpophalangeal joints [2]. * **Endocrine:** Iron deposition in the pituitary gland leads to decreased gonadotropin secretion, resulting in **hypogonadism** (loss of libido, impotence). * **Pancreas:** Damage to islets causes **Diabetes Mellitus**. **Why other options are incorrect:** * **B. Ectopic ACTH secreting tumor:** While this causes hyperpigmentation (due to MSH-like activity of ACTH), it typically presents with features of Cushing syndrome (weight gain, hypertension) rather than arthritis or hypogonadism [4]. * **C. Wilson’s Disease:** This is a disorder of copper metabolism [3]. It presents with liver cirrhosis, Kayser-Fleischer (KF) rings in the eye, and neurological/psychiatric symptoms (tremors, parkinsonism), not the specific triad of bronzing and arthritis. * **D. Rheumatoid Arthritis:** While this explains the arthritis, it does not account for hyperpigmentation or endocrine dysfunction like hypogonadism. **High-Yield Pearls for NEET-PG:** * **Gene Mutation:** Most commonly the **HFE gene** (C282Y mutation) on Chromosome 6. * **Stain:** **Prussian Blue** stain is used to visualize hemosiderin (iron) in liver biopsies [1]. * **Cardiac Involvement:** Can lead to Restrictive or Dilated Cardiomyopathy. * **Screening:** Best initial test is **Transferrin Saturation** (>45%); Gold standard for diagnosis is **Liver Biopsy** (to calculate Hepatic Iron Index) [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 854-855. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Osteoarticular And Connective Tissue Disease, pp. 683-684. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 394-395. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 420-421.

Question 338: Bilirubin is the degradation product of which of the following?

A. Albumin
B. Globulin
C. Heme (Correct Answer)
D. Transferrin

Explanation: **Explanation:** **Bilirubin** is the end product of **heme catabolism**. Approximately 80–85% of bilirubin is derived from the breakdown of hemoglobin from senescent (aged) red blood cells in the reticuloendothelial system (spleen, liver, and bone marrow) [1]. The remaining 15–20% comes from the turnover of other heme-containing proteins like myoglobin and cytochromes. The biochemical pathway involves two key steps: 1. **Heme Oxygenase** breaks down heme into **biliverdin** (releasing iron and carbon monoxide) [2]. 2. **Biliverdin Reductase** then reduces biliverdin into unconjugated bilirubin [2]. **Analysis of Incorrect Options:** * **Albumin:** This is a transport protein. While bilirubin binds to albumin for transport in the blood to the liver [1], albumin itself is not a precursor to bilirubin. * **Globulin:** These are a group of proteins (including immunoglobulins and transport proteins). They are not involved in the pigment degradation pathway [3]. * **Transferrin:** This is the plasma protein responsible for transporting iron [3]. While it carries the iron released during heme breakdown, it is not degraded into bilirubin. **High-Yield Clinical Pearls for NEET-PG:** * **Rate-limiting step:** Heme oxygenase is the rate-limiting enzyme in bilirubin production. * **Carbon Monoxide (CO):** Heme degradation is the only endogenous source of CO in the human body. * **Van den Bergh Reaction:** Used to differentiate between conjugated (direct) and unconjugated (indirect) bilirubin. * **Crigler-Najjar & Gilbert Syndrome:** These result from defects in the enzyme **UGT1A1**, which is responsible for conjugating bilirubin in the liver [1], [2]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 384-385. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 858-860. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 587-588.

Question 339: Increased IgA levels are seen in which of the following conditions?

A. Alcoholic hepatitis
B. Alcoholic cirrhosis (Correct Answer)
C. Microvescicular fatty change
D. Macrovesicular fatty change

Explanation: **Explanation:** The correct answer is **Alcoholic Cirrhosis**. **Why Alcoholic Cirrhosis is correct:** In alcoholic liver disease, particularly at the stage of cirrhosis, there is a characteristic increase in serum **Immunoglobulin A (IgA)** levels [1]. This occurs due to two primary mechanisms: 1. **Shunting:** In cirrhosis, portal hypertension causes blood to bypass the liver (portosystemic shunting). This prevents the hepatic Kupffer cells from clearing gut-derived antigens, leading to an exaggerated systemic immune response and increased IgA production. 2. **Decreased Clearance:** The damaged hepatocytes and impaired biliary excretion in cirrhosis lead to reduced clearance of IgA-antigen complexes from the circulation. A classic diagnostic finding on immunofluorescence in alcoholic cirrhosis is the **"IgA creeping"** or linear IgA deposition along the hepatic sinusoids. **Why other options are incorrect:** * **Alcoholic Hepatitis:** While inflammatory markers (like CRP and leukocytosis) and AST/ALT ratios (>2:1) are elevated [2], a significant, diagnostic rise in IgA is specifically associated with the structural architectural changes of cirrhosis. * **Microvesicular and Macrovesicular Fatty Change (Steatosis):** These represent the earliest, reversible stages of alcoholic liver disease [2]. At these stages, the hepatic architecture is preserved, and there is no significant portosystemic shunting or immune activation to cause elevated IgA levels. **NEET-PG High-Yield Pearls:** * **Hypergammaglobulinemia Patterns:** * **IgA elevation:** Alcoholic Cirrhosis [1]. * **IgM elevation:** Primary Biliary Cholangitis (PBC) [1]. * **IgG elevation:** Autoimmune Hepatitis. * **Mallory-Denk Bodies:** Ubiquitinated intermediate filaments (keratin 8/18) seen in alcoholic hepatitis (but not pathognomonic) [2]. * **AST > ALT:** Typical of alcoholic liver disease because alcohol is a mitochondrial toxin, and AST is a mitochondrial enzyme. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 388-389. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, p. 848.

Question 340: In a chronic alcoholic, all the following may be seen in the liver except?

A. Fatty degeneration
B. Chronic hepatitis
C. Granuloma formation (Correct Answer)
D. Cholestatic hepatitis

Explanation: Alcoholic liver disease (ALD) follows a well-defined spectrum of histopathological changes [1]. The correct answer is **Granuloma formation**, as this is not a feature of alcohol-induced liver injury. [1] ### 1. Why Granuloma formation is the correct answer Granuloma formation in the liver is typically a response to chronic inflammatory stimuli such as infections (Tuberculosis, Sarcoidosis, Leprosy, Schistosomiasis) or certain drugs (Allopurinol, Sulfonamides) [1]. Alcohol causes direct hepatotoxicity and oxidative stress leading to steatosis and fibrosis, but it does not trigger the Type IV hypersensitivity reaction required for granuloma formation. [1] ### 2. Explanation of Incorrect Options * **Fatty degeneration (Steatosis):** This is the earliest and most common response to alcohol [2, 3]. It occurs due to an increased NADH/NAD+ ratio, which inhibits fatty acid oxidation and promotes triglyceride synthesis. [3] * **Chronic hepatitis:** Prolonged alcohol consumption leads to chronic inflammation, characterized by hepatocyte swelling (ballooning degeneration), Mallory-Denk bodies (cytokeratin intermediate filaments), and neutrophilic infiltration. [2, 3] * **Cholestatic hepatitis:** Severe alcoholic hepatitis can present with features of cholestasis, including bile plugs in canaliculi and bilirubin stasis, often manifesting clinically as deep jaundice. [2] ### 3. NEET-PG High-Yield Pearls * **Mallory-Denk Bodies:** These are eosinophilic cytoplasmic inclusions seen in alcoholic hepatitis (also seen in Wilson’s disease and NASH). [2, 3] * **Fibrosis Pattern:** Alcohol typically causes "chicken-wire" fibrosis (perisinusoidal/pericellular fibrosis). [2, 3] * **AST:ALT Ratio:** In alcoholic liver disease, the ratio is typically **>2:1** (due to pyridoxal phosphate deficiency affecting ALT more than AST). * **First change:** Steatosis (Fatty liver) is the earliest, reversible change. [3] **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 401-402. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 388-389. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 848-850.

Practice by Chapter

Jaundice and Cholestasis

Practice Questions

Viral Hepatitis

Practice Questions

Alcoholic and Non-alcoholic Fatty Liver Disease

Practice Questions

Drug and Toxin Induced Liver Injury

Practice Questions

Cirrhosis and Its Complications

Practice Questions

Metabolic Liver Diseases

Practice Questions

Liver Tumors

Practice Questions

Gallbladder and Biliary Tract Diseases

Practice Questions

Congenital Liver Diseases

Practice Questions

Liver Transplantation Pathology

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free